Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Drug Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis method for Syk inhibitor intermediate via selective nitration and hydrazine reduction, offering high yield and scalability for pharma supply chains.
Patent CN106631957A reveals FAP-alpha targeting compound reducing toxicity. Offers cost reduction in antitumor drug manufacturing and reliable supply chain solutions.
Patent CN115850252A discloses a novel iron-iodine co-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN101973954A reveals a green, aqueous synthesis route for 3,4-dihydro-1,3-oxazin-2-ones, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101701027B details a novel catalytic cracking method for nucleosides, offering high-yield production of tetraacetyl ribofuranose and acetylated purines for reliable pharmaceutical intermediates supply chains.
Patent CN115925609A details a green FeCl2-catalyzed route to 3-alkenyl oxindoles. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN115385920A details a scalable BTK inhibitor refining method achieving 99.4% purity without column chromatography, offering significant cost reduction in API manufacturing.
Novel 3-step route for kinase inhibitor intermediates eliminates high-pressure CO. Enhances safety and scalability for reliable pharmaceutical supply chains.
Patent CN113512733B details an electrochemical NHK reaction for Eribulin intermediate ERB, offering greener synthesis, reduced reaction time, and improved scalability for pharmaceutical manufacturing.
Novel scalable process for NUC-7738 anticancer prodrug. Enhanced diastereomer enrichment and cost-effective protecting group strategy for pharmaceutical manufacturing.
Discover advanced processes for preparing cyclopenta[d]pyrimidin-4-yl piperazine compounds. Enhance supply chain reliability and reduce manufacturing costs for AKT inhibitors.
Novel nickel-catalyzed oxidation route for Acalabrutinib key intermediate reduces cost and pollution while ensuring high purity for pharma supply chains.
Patent CN113563305B reveals a cost-effective, high-yield route for 2-(4-phenoxyphenyl)-6-(N-substituted oxycarbonyl piperidine-4-) nicotinamide, ensuring reliable supply chain stability.
Optimized synthesis of 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid via copper catalysis. Reduces heavy metal residue and cost for API manufacturing.
Patent CN113527081B reveals a safer Mitsunobu route for 3-oxocyclobutanecarboxylic acid. Discover cost reduction in pharma intermediate manufacturing and scalable supply solutions.
Patent CN110194760B reveals a one-pot Pd-catalyzed route for isoindolinone intermediates, offering high yields and simplified supply chains for API manufacturing.
Solve high-cost deuteration challenges with 98% deuterated aldehyde yield. Our CDMO expertise in metal-free catalysis ensures scalable, pure intermediates for drug development.
Solve toxic reagent risks in phenanthridinone production. Discover 1 atm CO pressure process for high-yield, scalable API intermediates with reduced supply chain risks.
Solve quinoline-4(1H)-one synthesis challenges with this one-step palladium-catalyzed method. Reduce costs, improve yield, and ensure supply chain stability for your API production.
Discover how palladium-catalyzed carbonylation enables cost-effective, high-yield synthesis of 2-trifluoromethyl quinazolinone for drug development. Reduce supply chain risks and improve scalability.